Publications by authors named "Hakan Bor"
Case Rep Endocrinol
December 2023
Article Synopsis
- CFTR modulator therapies, like elexacaftor, tezacaftor, and ivacaftor, enhance respiratory function and glycaemic control in cystic fibrosis patients, but their effects on pancreatic function in those without diabetes remain uncertain.
- A case study of an 18-year-old female with cystic fibrosis, who developed hypoglycaemia after starting CFTR therapy, indicates that these treatments may influence glucose regulation even in non-diabetic patients.
- Managing diet, particularly by avoiding high glycaemic index foods, helped reduce her hypoglycaemic episodes, suggesting CFTR modulator therapies could impact insulin secretion and insulin resistance in cystic fibrosis patients. *
